Workflow
Tech ETFs at the Forefront of the Market Rebound on Monday
ZACKS· 2025-08-05 23:10
U.S. stocks rebounded sharply on Monday, staging a comeback from last week’s sell-off driven by weak labor market data and escalating trade tensions. The S&P 500 rose 1.5%, while the Dow Jones jumped 1.3%, marking one of its strongest days in months. The Nasdaq Composite Index outperformed, gaining 1.9% and recording its best daily performance since May.Stronger-than-expected earnings from major corporations, including Tyson Foods (TSN), upbeat economic data and growing Fed rate cut speculation helped boost ...
Best Momentum Stock to Buy for August 5th
ZACKS· 2025-08-05 23:01
F5公司(FFIV) - 公司为全球互联网流量管理提供产品和服务,Zacks评级为1级(强力买入) [1] - 过去60天内,当前年度盈利的Zacks共识预期增长4.9% [1] - 过去三个月股价上涨20.1%,同期标普500指数涨幅为12%,动量评分为A级 [1] Indivior公司(INDV) - 公司为专业制药企业,专注于酒精成瘾、阿片类药物过量、可卡因中毒及精神分裂症等共病症的药物治疗研发 [2] - 过去60天内,当前年度盈利的Zacks共识预期大幅增长26.1% [2] - 过去三个月股价飙升78.4%,显著超越标普500指数12%的涨幅,动量评分为A级 [3] nVent Electric公司(NVT) - 公司提供电气连接与保护解决方案,涵盖设计、制造、安装及维护服务 [3] - 过去60天内,当前年度盈利的Zacks共识预期增长6.5% [3] - 过去三个月股价上涨48.6%,远超标普500指数12%的涨幅,动量评分为A级 [4]
XP Inc.A (XP) to Report Q2 Results: Wall Street Expects Earnings Growth
ZACKS· 2025-08-05 23:01
Wall Street expects a year-over-year increase in earnings on higher revenues when XP Inc.A (XP) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move low ...
Compared to Estimates, Marriott (MAR) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-05 23:01
Marriott International (MAR) reported $6.74 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 4.7%. EPS of $2.65 for the same period compares to $2.50 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $6.67 billion, representing a surprise of +1.17%. The company delivered an EPS surprise of +0.38%, with the consensus EPS estimate being $2.64.While investors scrutinize revenue and earnings changes year-over-year and how they compare with W ...
Standard Motor Products (SMP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-08-05 23:01
Standard Motor Products (SMP) reported $493.85 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 26.7%. EPS of $1.29 for the same period compares to $0.98 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $449.97 million, representing a surprise of +9.75%. The company delivered an EPS surprise of +32.99%, with the consensus EPS estimate being $0.97.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...
Compared to Estimates, ADM (ADM) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-05 23:01
财务表现 - 公司2025年第二季度营收为2117亿美元 同比下降49 [1] - 每股收益093美元 低于去年同期的103美元 [1] - 营收超出市场预期2111亿美元 超出幅度028 [1] - 每股收益超出市场预期088美元 超出幅度568 [1] 业务细分表现 - 油籽加工量9051千吨 高于分析师预期的8872千吨 [4] - 碳水化合物解决方案部门营收279亿美元 低于分析师预期的287亿美元 同比下降35 [4] - 农业服务与油籽部门营收1627亿美元 高于分析师预期的1617亿美元 同比下降61 [4] - 营养部门营收199亿美元 高于分析师预期的192亿美元 同比增长45 [4] - 其他业务营收112亿美元 低于分析师预期的11404亿美元 同比下降09 [4] 部门运营利润 - 碳水化合物解决方案部门运营利润337亿美元 高于分析师预期的3012亿美元 [4] - 营养部门总运营利润114亿美元 低于分析师预期的12602亿美元 [4] - 营养部门动物营养业务运营利润22亿美元 高于分析师预期的1968亿美元 [4] - 农业服务与油籽部门总运营利润379亿美元 低于分析师预期的48641亿美元 [4] - 农业服务与油籽部门农业服务业务运营利润113亿美元 低于分析师预期的1911亿美元 [4] - 农业服务与油籽部门压榨业务运营利润33亿美元 低于分析师预期的12682亿美元 [4] - 其他业务运营利润94亿美元 高于分析师预期的84亿美元 [4] 市场表现 - 公司股价过去一个月下跌03 同期标普500指数上涨1 [3] - 公司当前Zacks评级为4级(卖出) 预示短期内可能跑输大盘 [3]
Compared to Estimates, Embraer (ERJ) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-05 23:01
Embraer (ERJ) reported $1.82 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 21.8%. EPS of -$0.02 for the same period compares to $0.44 a year ago.The reported revenue represents a surprise of +8.88% over the Zacks Consensus Estimate of $1.67 billion. With the consensus EPS estimate being $0.47, the EPS surprise was -104.26%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street exp ...
Bitfarms Ltd. (BITF) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-08-05 23:01
The market expects Bitfarms Ltd. (BITF) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 12, might help the stock move higher if these key numbers are bette ...
Earnings Preview: Cava Group (CAVA) Q2 Earnings Expected to Decline
ZACKS· 2025-08-05 23:01
The market expects Cava Group (CAVA) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-08-05 23:01
公司业绩预期 - Inovio Pharmaceuticals预计在2025年6月季度报告中每股亏损0.63美元,同比改善47.1%,但营收预计为5万美元,同比下降50% [3] - 过去30天内,分析师将共识EPS预期上调4.55%,反映对业绩前景的重新评估 [4] - 公司最近四个季度中有三次超过EPS预期,最近一次季度实际亏损0.51美元,比预期亏损0.74美元高出31.08%的正面意外 [12][13] 业绩预测模型 - Zacks Earnings ESP模型通过比较最准确估计与共识估计来预测业绩意外,最准确估计包含分析师最新信息 [7] - 对于Inovio,最准确估计高于共识估计,产生+10.76%的ESP值,结合Zacks Rank 3,显示很可能超过EPS预期 [11] - 历史数据显示,具有正ESP和Zacks Rank 1-3的股票有近70%概率实现业绩超预期 [9] 行业比较 - 同行业公司VistaGen Therapeutics预计季度每股亏损0.47美元,同比下降34.3%,但营收预计65万美元,同比大增712.5% [17][18] - VistaGen过去30天共识EPS预期上调4.9%,但ESP为-3.52%,结合Zacks Rank 3,难以预测其将超过预期 [18][19] - VistaGen过去四个季度中也有三次超过EPS预期 [19] 市场影响 - 实际业绩与预期的对比将显著影响Inovio短期股价,超预期可能推动股价上涨,不及预期则可能导致下跌 [1][2] - 业绩电话会上管理层对业务状况的讨论将决定股价变动的持续性和未来盈利预期 [2] - 虽然业绩超预期是重要因素,但其他催化剂也可能导致股价与业绩表现背离 [14][15]